An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Alzheimer's Disease
Interventions
DRUG

memantine HCl

Trial Locations (9)

23502

Hampton Roads Center for Clinical Research, Norfolk

33016

Berma Research Group, Hialeah

33154

Baumel-Eisner Neuromedical Institute, Miami

33407

Premiere Research Institute, West Palm Beach

92683

Coastal Communities Hospital, Westminster

94115

The Forves Norris MDA/ALS Research Center, San Francisco

96817

Geriatric Medicine, Honolulu

06510

Alzheimer's Disease Research Unit, New Haven

05201

The Memory Clinic, Bennington

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY

NCT00097916 - An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease | Biotech Hunter | Biotech Hunter